Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766

Comprehensive molecular characterization of human colon and rectal cancer

The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499

Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067

Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker

Heagerty, P. J., Lumley, T., & PEPE, M. S. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00337.x · Cited by 2,870

The Genomic Landscapes of Human Breast and Colorectal Cancers

Wood, L. D., Parsons, D. W., Jones, S., Lin, J., Sjöblom, T., Leary, R. J., Shen, D., Boca, S. M., Barber, T., Ptak, J., et al. (2007) · Science · doi:10.1126/science.1145720 · Cited by 2,833

Circulating mutant DNA to assess tumor dynamics

Diehl, F., Schmidt, K., Choti, M. A., Romans, K. E., Goodman, S. N., Li, M., Thornton, K. A., Agrawal, N., Sokoll, L. J., Szabo, S., et al. (2008) · Nature Medicine · doi:10.1038/nm.1789 · Cited by 2,746

Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer

Ribic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022289 · Cited by 2,160

Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

Misale, S., Yaeger, R., Hobor, S., Scala, E., Janakiraman, M., Liska, D., Valtorta, E., Schiavo, R., Buscarino, M., Siravegna, G., et al. (2012) · Nature · doi:10.1038/nature11156 · Cited by 1,889

The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

Diaz Jr, L. A., Williams, R. T., Wu, J., Kinde, I., Hecht, J. R., Berlin, J., Allen, B., Bozic, I., Reiter, J. G., Nowak, M. A., et al. (2012) · Nature · doi:10.1038/nature11219 · Cited by 1,713

Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer

Sargent, D. J., Marsoni, S., Monges, G., Thibodeau, S. N., Labianca, R., Hamilton, S. R., French, A. J., Kabat, B., Foster, N. R., Torri, V., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.1825 · Cited by 1,623

Stopping targeted therapy for complete responders in advanced BRAF mutant melanoma

Warburton, L., Meniawy, T. M., Calapre, L., Pereira, M. R., McEvoy, A. C., Ziman, M. R., Gray, E. S., & Millward, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-75837-5 · Cited by 29

Dynamic Changes of Post-Radiotherapy Plasma Epstein–Barr Virus DNA in a Randomized Trial of Adjuvant Chemotherapy Versus Observation in Nasopharyngeal Cancer

Hui, E. P., Ma, B. B. Y., Lam, W. K., Chan, K. C. A., Mo, F. K. F., Ai, Q. Y. H., King, A. D., Wong, C. H., Wong, K. C. W., Lam, D. C. M., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3519 · Cited by 29

Limited Sensitivity of Circulating Tumor DNA Detection by Droplet Digital PCR in Non-Metastatic Operable Gastric Cancer Patients

Cabel, L., Decraene, C., Bièche, I., Pierga, J., Bennamoun, M., Fuks, D., Ferraz, J., Lefèvre, M., Baulande, S., Bernard, V., et al. (2019) · Cancers · doi:10.3390/cancers11030396 · Cited by 29

Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level

Pozzo, A. R., Liu, S., Wajnberg, G., Wang, X., Ouellette, R. J., Hicks, G. G., Drachenberg, D., & Mai, S. (2020) · Cells · doi:10.3390/cells9081863 · Cited by 29

Applications of Liquid Biopsy for Surgical Patients With Cancer

Mahuron, K. M., & Fong, Y. (2023) · JAMA Surgery · doi:10.1001/jamasurg.2023.5394 · Cited by 31

Circulating tumor DNA methylation: a promising clinical tool for cancer diagnosis and management

Wang, B., Wang, M., Lin, Y., Zhao, J., Gu, H., & Li, X. (2024) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2023-1327 · Cited by 29

Facile single-stranded DNA sequencing of human plasma DNA via thermostable group II intron reverse transcriptase template switching

Wu, D. C., & Lambowitz, A. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-09064-w · Cited by 30

Cell-Free DNA in the Liquid Biopsy Context: Role and Differences Between ctDNA and CTC Marker in Cancer Management

Fici, P. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8973-7_4 · Cited by 29

Disease Monitoring Using Post-induction Circulating Tumor DNA Analysis Following First-Line Therapy in Patients with Metastatic Colorectal Cancer

Ma, X. M., Bendell, J. C., Hurwitz, H. I., Ju, C., Lee, J. J., Lovejoy, A., Mancao, C., Nicholas, A., Price, R., Sommer, N., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1209 · Cited by 28

Dynamic analysis of circulating tumor DNA to predict prognosis and monitor therapeutic response in metastatic relapsed cervical cancer

Tian, X., Ge, D., Zhang, F., Zhang, B., Bai, W., Xu, X., Li, Z., Cao, Y., Li, P., Zou, K., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33362 · Cited by 28

Clinical Applications of Minimal Residual Disease Assessments by Tumor-Informed and Tumor-Uninformed Circulating Tumor DNA in Colorectal Cancer

Gong, J., Hendifar, A. E., Gangi, A., Zaghiyan, K. N., Atkins, K. M., Nasseri, Y. Y., Murrell, Z. A., Figueiredo, J. C., Salvy, S., Haile, R. W., et al. (2021) · Cancers · doi:10.3390/cancers13184547 · Cited by 28

Where Are We Now and Where Might We Be Headed in Understanding and Managing Brain Metastases in Colorectal Cancer Patients?

Mjahed, R. B., Astaras, C., Roth, A. D., & Koessler, T. (2022) · Current Treatment Options in Oncology · doi:10.1007/s11864-022-00982-0 · Cited by 28

Introduction of Nanomaterials to Biosensors for Exosome Detection: Case Study for Cancer Analysis

Lee, M., Kim, J., Jang, M., Park, C., Lee, J., & Lee, T. (2022) · Biosensors · doi:10.3390/bios12080648 · Cited by 28

Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases

Marmorino, F., Prisciandaro, M., Giordano, M., Ortolan, E., Crucitta, S., Manca, P., Antoniotti, C., Valenti, M., Danesi, R., Conca, V., et al. (2022) · JCO Precision Oncology · doi:10.1200/po.22.00244 · Cited by 30

The methylome and cell-free DNA: current applications in medicine and pediatric disease

Spector, B. L., Harrell, L., Sante, D., Wyckoff, G. J., & Willig, L. K. (2023) · Pediatric Research · doi:10.1038/s41390-022-02448-3 · Cited by 29

Circulating tumor DNA detection after neoadjuvant treatment and surgery predicts recurrence in patients with early-stage and locally advanced rectal cancer

Hofste, L. S. M., Geerlings, M. J., von Rhein, D. T., Rütten, H., Westenberg, A. H., Weiss, M. M., Gilissen, C., Hofste, T. G. J., van der Post, R. S., Klarenbeek, B. R., et al. (2023) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2023.01.026 · Cited by 29

Cell-free DNA as a post-treatment surveillance strategy: current status

Burgener, J., Rostami, A., Carvalho, D. D. D., & Bratman, S. V. (2017) · Seminars in Oncology · doi:10.1053/j.seminoncol.2018.01.009 · Cited by 26

Sensitive detection of microsatellite instability in tissues and liquid biopsies: Recent developments and updates

Yu, F., Makrigiorgos, A., Leong, K. W., & Makrigiorgos, G. M. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.08.037 · Cited by 27

BRAF-mutated colorectal adenocarcinomas: Pathological heterogeneity and clinical implications

Angerilli, V., Sabella, G., Centonze, G., Lonardi, S., Bergamo, F., Mangogna, A., Pietrantonio, F., Fassan, M., & Milione, M. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103647 · Cited by 27

Circulating Tumor DNA-Based Disease Monitoring of Patients with Locally Advanced Esophageal Cancer

Hofste, L. S. M., Geerlings, M. J., von Rhein, D. T., Tolmeijer, S. H., Weiss, M. M., Gilissen, C., Hofste, T. G. J., Garms, L. M., Janssen, M. J. R., Rütten, H., et al. (2022) · Cancers · doi:10.3390/cancers14184417 · Cited by 27

Clinical application of liquid biopsy in endometrial carcinoma

Shen, Y., Shi, R., Zhao, R., & Wang, H. (2023) · Medical Oncology · doi:10.1007/s12032-023-01956-4 · Cited by 27

Circulating tumor DNA: clinical roles in diffuse large B cell lymphoma

Wu, F., Luo, L., Xu, W., & Li, J. (2018) · Annals of Hematology · doi:10.1007/s00277-018-3529-9 · Cited by 26

Development and Clinical Validation of Discriminatory Multitarget Digital Droplet PCR Assays for the Detection of Hot Spot KRAS and NRAS Mutations in Cell-Free DNA

Hussung, S., Follo, M., Klar, R. F. U., Michalczyk, S., Fritsch, K., Nollmann, F. I., Hipp, J., Duyster, J., Scherer, F., von Bubnoff, N. C. C., et al. (2020) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2020.04.206 · Cited by 28

Circulating cell-free DNA methylation patterns as non-invasive biomarkers to monitor colorectal cancer treatment efficacy without referencing primary site mutation profiles

Yasui, K., Toshima, T., Inada, R., Umeda, Y., Yano, S., Tanioka, H., Nyuya, A., Fujiwara, T., Yamada, T., Naomoto, Y., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-023-01910-y · Cited by 26

Analytical evaluation of circulating tumor DNA sequencing assays

Li, W., Huang, X., Patel, R. D., Schleifman, E., Fu, S., Shames, D. S., & Zhang, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-54361-w · Cited by 26

Translation of Epigenetics in Cell-Free DNA Liquid Biopsy Technology and Precision Oncology

Tan, W. Y., Nagabhyrava, S., Ang-Olson, O., Das, P., Ladel, L., Sailo, B., He, L., Sharma, A. R., & Ahuja, N. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46070390 · Cited by 28

Role of circulating tumor DNA in early-stage triple-negative breast cancer: a systematic review and meta-analysis

Zhang, D., Jahanfar, S., Rabinowitz, J. B., Dower, J., Song, F., Wu, C.-H., Hu, X., Tracy, P. A., Basik, M., Medford, A. J., et al. (2025) · Breast Cancer Research · doi:10.1186/s13058-025-01986-y · Cited by 26

Liquid biopsy in newly diagnosed patients with locoregional (I-IIIA) non-small cell lung cancer

Chen, K., Kang, G., Zhao, H., Zhang, K., Zhang, J., Yang, F., & Wang, J. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1599717 · Cited by 26

Personalized tumor-specific DNA junctions to detect circulating tumor in patients with endometrial cancer

Grassi, T., Harris, F. R., Smadbeck, J. B., Murphy, S. J., Block, M. S., Multinu, F., Klein, J. L. S., Zhang, P., Karagouga, G., Liu, M., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252390 · Cited by 25

Detection of KRAS mutations in circulating tumour DNA from plasma and urine of patients with colorectal cancer

Ohta, R., Yamada, T., Sonoda, H., Matsuda, A., Shinji, S., Takahashi, G., Iwai, T., Takeda, K., Ueda, K., Kuriyama, S., et al. (2021) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2021.07.017 · Cited by 27

Waiting for the “liquid revolution” in the adjuvant treatment of colon cancer patients: a review of ongoing trials

Conca, V., Ciracì, P., Boccaccio, C., Minelli, A., Antoniotti, C., & Cremolini, C. (2024) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2024.102735 · Cited by 26

Serum and tissue markers in colorectal cancer: State of art

Berretta, M., Alessandrini, L., Divitiis, C. D., Nasti, G., Lleshi, A., Francia, R. D., Facchini, G., Cavaliere, C., Buonerba, C., & Canzonieri, V. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.01.007 · Cited by 28

Longitudinal monitoring of ctDNA EGFR mutation burden from urine correlates with patient response to EGFR TKIs: A case series

Tchekmedyian, N., Mudad, R., Blanco, F. F., Raymond, V. M., Garst, J. H., Erlander, M. G., Haura, E. B., & Berz, D. (2017) · Lung Cancer · doi:10.1016/j.lungcan.2017.02.010 · Cited by 26

Utilizing circulating tumour DNA in radiation oncology

Rostami, A., & Bratman, S. V. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.07.004 · Cited by 26

Current applications and challenges of circulating tumor DNA (ctDNA) in squamous cell carcinoma of the head and neck (SCCHN)

Galot, R., & Machiels, J. (2020) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.101992 · Cited by 28

Personalized circulating tumor DNA monitoring improves recurrence surveillance and management after curative resection of colorectal liver metastases: a prospective cohort study

Li, Y., Xu, J., Hu, X., Chen, Y., Liu, F., Chen, Y. F., Ma, X., Dong, Q., Sun, L., Mo, S., et al. (2024) · International Journal of Surgery · doi:10.1097/js9.0000000000001236 · Cited by 27

Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment

Parikh, A. R., Chee, B. H., Tsai, J., Rich, T. A., Price, K. S., Patel, S. A., Zhang, L., Ibrahim, F., Esquivel, M., Seventer, E. E. V., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-3660 · Cited by 25

Combined Analyses of Circulating Tumor DNA and Immunoscore in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France/HORG-IDEA-Greece Trials

Taı̈eb, J., Souglakos, J., Boukovinas, I., Falcoz, A., Pagès, F., Messaritakis, I., Bennouna, J., Artru, P., Louvet, C., Lepère, C., et al. (2025) · Journal of Clinical Oncology · doi:10.1200/jco.24.00648 · Cited by 26

Clinical utility of circulating cell-free DNA in advanced colorectal cancer

Pereira, A. A. L., Morelli, M. P., Overman, M. J., Kee, B. K., Fogelman, D. R., Vilar, E., Shureiqi, I., Raghav, K. P. S., Eng, C., Manuel, S., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183949 · Cited by 25

Parallel Serial Assessment of Somatic Mutation and Methylation Profile from Circulating Tumor DNA Predicts Treatment Response and Impending Disease Progression in Osimertinib-Treated Lung Adenocarcinoma Patients

Xia, S., Ye, J., Chen, Y., Lizaso, A., Huang, L., Shi, L., Su, J., Han‐Zhang, H., Chuai, S., Li, L., et al. (2019) · Translational Lung Cancer Research · doi:10.21037/tlcr.2019.12.09 · Cited by 25

The value of circulation tumor DNA in predicting postoperative recurrence of colorectal cancer: a meta-analysis

Wang, R. Y., Zhao, A., Cao, N., Li, Z., Zhang, G., & Liu, F. (2020) · International Journal of Colorectal Disease · doi:10.1007/s00384-020-03667-y · Cited by 23

Reliability of liquid biopsy analysis: an inter-laboratory comparison of circulating tumor DNA extraction and sequencing with different platforms

Koessler, T., Paradiso, V., Piscuoglio, S., Nienhold, R., Ho, L. K. F., Christinat, Y., Terracciano, L., Cathomas, G., WICKI, A. N., McKee, T., et al. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-0459-7 · Cited by 26

Liquid biopsy in peritoneal fluid and plasma as a prognostic factor in advanced colorectal and appendiceal tumors after complete cytoreduction and hyperthermic intraperitoneal chemotherapy

López-Rojo, I., López, S. O., Villarejo‐Campos, P., Prieto, V. D., Barambio, J., Guiral, D. C., García‐Arranz, M., & García‐Olmo, D. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920981351 · Cited by 25

Preoperative detection of KRAS mutated circulating tumor DNA is an independent risk factor for recurrence in colorectal cancer

Nakamura, Y., Yokoyama, S., Matsuda, K., Tamura, K., Mitani, Y., Iwamoto, H., Mizumoto, Y., Murakami, D., Kitahata, Y., & Yamaue, H. (2021) · Scientific Reports · doi:10.1038/s41598-020-79909-4 · Cited by 24

Assessing CAR T-Cell Therapy Response Using Genome-Wide Sequencing of Cell-Free DNA in Patients With B-Cell Lymphomas

Goodman, A. M., Holden, K. A., Jeong, A., Kim, L., Fitzgerald, K. D., Almasri, E., McLennan, G., Eisenberg, M. T., Jahromi, A. H., Hoh, C. K., et al. (2021) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2021.10.007 · Cited by 25

Utility of Cell-Free DNA Detection in Transplant Oncology

Reddy, T. P., Esmail, A., Chang, J. C., Ghobrial, R. M., & Abdelrahim, M. (2022) · Cancers · doi:10.3390/cancers14030743 · Cited by 25

The Landscape of Actionable Genomic Alterations by Next-Generation Sequencing in Tumor Tissue Versus Circulating Tumor DNA in Chinese Patients With Non-Small Cell Lung Cancer

Cai, J., Jiang, H., Li, S., Xiaoxia, Y., Wang, M., Li, N., Zhu, C., Dong, H., Wang, D., Xu, Y., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.751106 · Cited by 26

Postoperative circulating tumor DNA can refine risk stratification in resectable lung cancer: results from a multicenter study

Fu, R., Huang, J., Tian, X., Liang, C., Xiong, Y., Zhang, J., Jiang, B., Dong, S., Gong, Y., Gao, W., et al. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13387 · Cited by 25

Evaluation of CD3 and CD8 T-Cell Immunohistochemistry for Prognostication and Prediction of Benefit From Adjuvant Chemotherapy in Early-Stage Colorectal Cancer Within the QUASAR Trial

Williams, C. J. M., Gray, R. G., Hills, R. K., Shires, M., Zhang, L., Zhao, Z., Gardner, T., Sapanara, N. L., Xu, X., Bai, I., et al. (2024) · Journal of Clinical Oncology · doi:10.1200/jco.23.02030 · Cited by 25

Understanding Intratumor Heterogeneity and Evolution in NSCLC and Potential New Therapeutic Approach

Goto, T., Hirotsu, Y., Amemiya, K., Mochizuki, H., & Omata, M. (2018) · Cancers · doi:10.3390/cancers10070212 · Cited by 25

Novel Methylated DNA Markers in the Surveillance of Colorectal Cancer Recurrence

Xie, H., Mahoney, D. W., Foote, P. H., Burger, K. N., Doering, K. A., Taylor, W. R., Then, S. S., Cao, X., McGlinch, M. C., Berger, C. K., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-2589 · Cited by 25

In vivo imaging of synaptic density with [11C]UCB-J PET in two mouse models of neurodegenerative disease

Xiong, M., Roshanbin, S., Rokka, J., Schlein, E., Ingelsson, M., Sehlin, D., Eriksson, J., & Syvänen, S. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118302 · Cited by 24

Non-metastatic colon cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatments, and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, AFEF, and SFR)

Lecomte, T., Tougeron, D., Chautard, R., Bressand, D., Bibeau, F., Blanc, B., Cohen, R., Jacques, J., Lagasse, J.-P., Laurent‐Puig, P., et al. (2024) · Digestive and Liver Disease · doi:10.1016/j.dld.2024.01.208 · Cited by 25

Advancements in Personalized CAR-T Therapy: Comprehensive Overview of Biomarkers and Therapeutic Targets in Hematological Malignancies

Olejarz, W., Sadowski, K. A., Szulczyk, D., & Basak, G. W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147743 · Cited by 26

Liquid biopsy for diagnostic and prognostic evaluation of melanoma

Slusher, N. J., Jones, N., & NONAKA, T. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1420360 · Cited by 29

Circulating Tumor DNA Testing for Minimal Residual Disease and Its Application in Colorectal Cancer

Abidoye, O., Ahn, D. H., Borad, M. J., Wu, C., Bekaii‐Saab, T., Chakrabarti, S., & Sonbol, M. B. (2025) · Cells · doi:10.3390/cells14030161 · Cited by 26

Multimodal integration of liquid biopsy and radiology for the noninvasive diagnosis of gallbladder cancer and benign disorders

Yang, M., Zhao, Y., Li, C., Weng, X., Li, Z., Guo, W., Jia, W., Feng, F., Hu, J., Sun, H., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.02.011 · Cited by 24

The potential role of circulating tumor DNA (ctDNA) in the further investigation of colorectal cancer patients with nonspecific findings on standard investigations

Wong, R., Tie, J., Lee, M., Cohen, J. D., Wang, Y., Li, L., Ma, S. B., Christie, M., Kosmider, S., Tomasetti, C., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32117 · Cited by 24

Novel Epigenetic Biomarkers in Pregnancy-Related Disorders and Cancers

Karin‐Kujundžić, V., Šola, I. M., Predavec, N., Potkonjak, A., Somen, E., Mioč, P., Šerman, A., Vranić, S., & Šerman, L. (2019) · Cells · doi:10.3390/cells8111459 · Cited by 25

A Serum Metabolomics Classifier Derived from Elderly Patients with Metastatic Colorectal Cancer Predicts Relapse in the Adjuvant Setting

Donato, S. D., Vignoli, A., Biagioni, C., Malorni, L., Mori, E., Tenori, L., Calamai, V., Parnofiello, A., Pierro, G. D., Migliaccio, I., et al. (2021) · Cancers · doi:10.3390/cancers13112762 · Cited by 25

Role of Circulating Tumor DNA in Gastrointestinal Cancers: Current Knowledge and Perspectives

Moati, É., Taly, V., Garinet, S., Didelot, A., Taı̈eb, J., Laurent‐Puig, P., & Zaanan, A. (2021) · Cancers · doi:10.3390/cancers13194743 · Cited by 25

Immune Checkpoint Inhibitors in Luminal Gastrointestinal Malignancies: Going Beyond MSI-H/dMMR, TMB and PD-L1

Lefler, D. S., Snook, A. E., & Bashir, B. (2022) · Immunotherapy · doi:10.2217/imt-2022-0012 · Cited by 25

UMIErrorCorrect and UMIAnalyzer: Software for Consensus Read Generation, Error Correction, and Visualization Using Unique Molecular Identifiers

Österlund, T., Filges, S., Johansson, G., & Ståhlberg, A. (2022) · Clinical Chemistry · doi:10.1093/clinchem/hvac136 · Cited by 25

In Vivo Detection of Circulating Tumor Cells in High-Risk Non-Metastatic Prostate Cancer Patients Undergoing Radiotherapy

Chen, S., Tauber, G., Langsenlehner, T., Schmölzer, L. M., Pötscher, M., Riethdorf, S., Kuske, A., Leitinger, G., Kashofer, K., Czyż, Z. T., et al. (2019) · Cancers · doi:10.3390/cancers11070933 · Cited by 24

Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trial

Auclin, É., André, T., Taı̈eb, J., Banzi, M. C., Laethem, J. V., Tabernero, J. M., Hickish, T., de Gramont, A., & Vernerey, D. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0521-7 · Cited by 24

Circulating cell-free long DNA fragments predict post-hepatectomy recurrence of colorectal liver metastases

Iwai, T., Yamada, T., Takahashi, G., Takeda, K., Koizumi, M., Shinji, S., Matsuda, A., Yokoyama, Y., Hara, K., Ueda, K., et al. (2019) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2019.08.010 · Cited by 24

Application of a novel self-assembling peptide to prevent hemorrhage after EMR, a feasibility and safety study

Soons, E., Turan, A. S., van Geenen, E., & Siersema, P. D. (2020) · Surgical Endoscopy · doi:10.1007/s00464-020-07819-7 · Cited by 24

Biomarkers for Precision Treatment in Gastric Cancer

Petrillo, A., & Smyth, E. C. (2020) · Visceral Medicine · doi:10.1159/000510489 · Cited by 25

Detection of Somatic Mutations with ddPCR from Liquid Biopsy of Colorectal Cancer Patients

Zmrzljak, U. P., Košir, R., Krivokapić, Z., Radojkovic, D. P., & Nikolić, A. (2021) · Genes · doi:10.3390/genes12020289 · Cited by 26

Post‑radiation circulating tumor DNA as a prognostic factor in locally advanced esophageal squamous cell carcinoma

Jia, R., Zhao, C., Li, P.-S., Liu, R., Zhang, Y., Chen, H.-E., Chang, L., Gong, Y., Guan, Y., Yi, X., et al. (2020) · Oncology Letters · doi:10.3892/ol.2020.12329 · Cited by 23

Sustainable Clinical Development of Adjuvant Chemotherapy for Colon Cancer

Oki, E., Ando, K., Taniguchi, H., Yoshino, T., & Mori, M. (2021) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12503 · Cited by 21

Tumor DNA From Tumor In Situ Fluid Reveals Mutation Landscape of Minimal Residual Disease After Glioma Surgery and Risk of Early Recurrence

Yu, J., Sheng, Z., Wu, S., Gao, Y., Yan, Z., Bu, C., Gu, J., Bu, Y., Deng, K., Xu, S., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.742037 · Cited by 22

Utility of plasma circulating tumor DNA and tumor DNA profiles in head and neck squamous cell carcinoma

Chikuie, N., Urabe, Y., Ueda, T., Hamamoto, T., Taruya, T., Kono, T., Yumii, K., & Takeno, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-13417-5 · Cited by 27

Essential updates 2020/2021: Advancing precision medicine for comprehensive rectal cancer treatment

Takemasa, I., Hamabe, A., Miyo, M., Akizuki, E., & Okuya, K. (2022) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12646 · Cited by 22

Prognostic and predictive value of Immunoscore and its correlation with ctDNA in stage II colorectal cancer

Wang, F., Lu, S., Cao, D., Qian, J., Li, C., Zhang, R., Wang, F., Wu, M., Liu, Y., Pan, Z., et al. (2023) · OncoImmunology · doi:10.1080/2162402x.2022.2161167 · Cited by 23

Copy Number Variations as Determinants of Colorectal Tumor Progression in Liquid Biopsies

Debattista, J., Grech, L., Scerri, C. A., & Grech, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021738 · Cited by 22

Epigenetic liquid biopsies for minimal residual disease, what’s around the corner?

Johnston, A. D., Ross, J. P., Ma, C., Fung, K. Y. C., & Locke, W. J. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1103797 · Cited by 23

The optimal time of starting adjuvant chemotherapy after curative surgery in patients with colorectal cancer

Yang, Y., Lü, Y., Tan, H. S., Bai, M., Wang, X., Ge, S., Ning, T., Zhang, L., Duan, J., Sun, Y., et al. (2023) · BMC Cancer · doi:10.1186/s12885-023-10863-w · Cited by 24

Ultra-short cell-free DNA fragments enhance cancer early detection in a multi-analyte blood test combining mutation, protein and fragmentomics

Wang, F., Li, X., Li, M., Liu, W., Lu, L., Li, Y., Chen, X., Yang, S., Liu, T., Cheng, W., et al. (2023) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2023-0541 · Cited by 23

Future perspectives of circulating tumor DNA in colorectal cancer

Nadal, C., Winder, T. L., Gerger, A., & Tougeron, D. (2017) · Tumor Biology · doi:10.1177/1010428317705749 · Cited by 26

Analysis of solid tumor mutation profiles in liquid biopsy

Andugulapati, S. B., Shanmugam, A., Chougule, A., Sridharan, S., Prabhash, K., Arya, A., Chaubey, A., Hariharan, A. K., Kolekar, P. S., Sen, M., et al. (2018) · Cancer Medicine · doi:10.1002/cam4.1791 · Cited by 22

Toward liquid biopsies in cancer treatment: application of circulating tumor DNA

Ahlborn, L. B., & Østrup, O. (2019) · Apmis · doi:10.1111/apm.12912 · Cited by 25

Targeted sequencing of circulating cell-free DNA in stage II-III resectable oesophageal squamous cell carcinoma patients

Meng, P., Wei, J., Geng, Y., Chen, S., Terpstra, M. M., Huang, Q., Zhang, Q., Su, Z., Yu, W., Su, M., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-6025-2 · Cited by 23

Detection of circulating tumor DNA in patients of operative colorectal and gastric cancers

Suzuki, T., Suzuki, T., Yoshimura, Y., Yahata, M., Yew, P. Y., Nakamura, T., Nakamura, Y., Park, J.-H., & Matsuo, R. (2020) · Oncotarget · doi:10.18632/oncotarget.27682 · Cited by 23

Circulating tumor DNA is a sensitive marker for routine monitoring of treatment response in advanced colorectal cancer

Zou, D., Day, R. C., Cocadiz, J. A., Parackal, S., Mitchell, W., Black, M. A., Lawrence, B. J., Fitzgerald, S. J., Print, C. G., Jackson, C., et al. (2020) · Carcinogenesis · doi:10.1093/carcin/bgaa102 · Cited by 23

Liquid Biopsy for Precision Adjuvant Chemotherapy in Colon Cancer

Montagut, C. O., & Vidal, J. (2022) · New England Journal of Medicine · doi:10.1056/nejme2204625 · Cited by 23

Multimodal Management of Colorectal Liver Metastases: State of the Art

Filoni, E., Musci, V., Rito, A. D., Inchingolo, R., Memeo, R., & Mannavola, F. (2024) · Oncology Reviews · doi:10.3389/or.2023.11799 · Cited by 22

Hunting for the ultimate liquid cancer biopsy - let the TEP dance begin

Feller, S. M., & Lewitzky, M. (2016) · Cell Communication and Signaling · doi:10.1186/s12964-016-0147-9 · Cited by 22

Use of Circulating Cell-Free DNA to Guide Precision Medicine in Patients with Colorectal Cancer

Morris, V. K., & Strickler, J. H. (2021) · Annual Review of Medicine · doi:10.1146/annurev-med-070119-120448 · Cited by 23

Hepatic Clearance of Cell-Free DNA: Possible Impact on Early Metastasis Diagnosis

Khier, S., & Gahan, P. B. (2021) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-021-00554-2 · Cited by 22

Synonymous Variants: Necessary Nuance in Our Understanding of Cancer Drivers and Treatment Outcomes

Kaissarian, N. M., Meyer, D., & Kimchi‐Sarfaty, C. (2022) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djac090 · Cited by 21

Circulating tumor DNA (ctDNA) to evaluate minimal residual disease (MRD), treatment response, and posttreatment prognosis in pancreatic adenocarcinoma

Ueberroth, B. E., Jones, J. C., & Bekaii‐Saab, T. (2022) · Pancreatology · doi:10.1016/j.pan.2022.06.009 · Cited by 24

Detection of methylated BCAT1 and IKZF1 after curative‐intent treatment as a prognostic indicator for colorectal cancer recurrence

Pedersen, S. K., Symonds, E. L., Roy, A. C., Cornthwaite, K. J., LaPointe, L. C., & Young, G. P. (2022) · Cancer Medicine · doi:10.1002/cam4.5008 · Cited by 21

Cell-free DNA as a biomarker in cancer

Eibl, R. H., & Schneemann, M. (2022) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2022.20 · Cited by 22

Complex RNA world in small extracellular vesicles for liquid biopsy in cancer management

Wang, S., Lin, Y., Zhang, Y., Qiu, X., Pan, Y., Yeung, S. J., & Zhang, H. (2022) · Extracellular Vesicle · doi:10.1016/j.vesic.2022.100015 · Cited by 22

Minimal Residual Disease in Colorectal Cancer: Are We Finding the Needle in a Haystack?

Jacome, A. A. D. A., & Johnson, B. (2023) · Cells · doi:10.3390/cells12071068 · Cited by 25

Clinical relevance of molecular diagnostics in gastrointestinal (GI) cancer: European Society of Digestive Oncology (ESDO) expert discussion and recommendations from the 17th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona

Baraniskin, A., Laethem, J. V., Wyrwicz, L. S., Güller, U., Wasan, H. S., Matysiak‐Budnik, T., Gruenberger, T., Ducreux, M. P., Carneiro, F., Cutsem, E. V., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.09.021 · Cited by 23

Predicting Relapse with Circulating Tumor DNA Analysis in Lung Cancer

Comino‐Méndez, I., & Turner, N. C. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1086 · Cited by 22

Integrating Biomarkers and Targeted Therapy Into Colorectal Cancer Management

Lieu, C. H., Corcoran, R. B., & Overman, M. J. (2019) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_240839 · Cited by 22

Liquid Biopsy by Next-Generation Sequencing: a Multimodality Test for Management of Cancer

Achi, H. E., Khoury, J. D., & Loghavi, S. (2019) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-019-00532-w · Cited by 22

Detection of minimal residual disease by circulating tumour DNA and risk of recurrence in Stage I–III colorectal cancer: the CITCCA study

Merk, C., Birkeälv, S., Strandberg, R., Bergström, R., Putcha, G. V., Mayrhofer, M., Howarth, K., Lindberg, J., & Martling, A. (2026) · British journal of surgery · doi:10.1093/bjs/znag093.030

Circulating tumor DNA to detect minimal residual disease, response to adjuvant therapy, and identify patients at high risk of recurrence in patients with stage I-III CRC.

Tarazona, N., Henriksen, T. V., Carbonell‐Asins, J. A., Reinert, T., Sharma, S., Roda, D., Shchegrova, S., Huerta, M., Roselló, S., Renner, D., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.2020.38.15_suppl.4009 · Cited by 19

Circulating tumor DNA (ctDNA) as a marker of recurrence risk in stage II colon cancer (CC).

Tie, J., Kinde, I., Wang, Y., Wong, H., Skinner, I., Wong, R., Steel, M., Diaz, L. A., Papadopoulos, N., Kosmider, S., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.32.15_suppl.11015 · Cited by 19

Postoperative circulating tumor DNA in stage II colon cancer: biological rationale, clinical evidence, and unresolved challenges

Yang, E., Wang, X., Zhang, J., Zhao, D., Yang, Z., Li, X., He, G., Guo, T., Wang, R., & Yuan, B. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1908802

Use of circulating tumor DNA analysis to predict recurrence and need for adjuvant chemotherapy in stage I-IV colorectal cancer.

Li, L., Fan, W., Xia, Z., Chen, R., Lin, D., Li, F., Zheng, Y., Luo, J., Xiong, Y., Yu, P., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.2023.41.16_suppl.e15537